EUVIMEDEUVIMED entdecken
MetaanalyseÜbersichtsarbeitOpen Access · CC BY 4.0

Changes of long-term survival of resection and liver transplantation in hepatocellular carcinoma throughout the years: A meta-analysis

Moritz Drefs, Markus B Schoenberg, Nikolaus Börner, Dionysios Koliogiannis, Dominik T Koch, Malte J Schirren, Joachim Andrassy, Alexandr V Bazhin, Jens Werner, Markus O Guba

European Journal of Surgical Oncology · 2024

DOI: 10.1016/j.ejso.2024.107952 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift European Journal of Surgical Oncology, 2024. Verfasst von Moritz Drefs und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of General, Visceral and Transplantation Surgery, LMU University Hospital, LMU Munich, Germany. Electronic address: moritz.drefs@med.uni-m…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Transplantation, Liver Neoplasms. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Hepatocellular Carcinoma (HCC) still is one of the most detrimental malignant diseases in the world. As two curative surgical therapies exist, the discussion whether to opt for liver resection (LR) or transplantation (LT) is ongoing, especially as novel techniques to improve outcome have emerged for both. The aim of the study was to investigate how the utilization and outcome of the respective modalities changed through time. METHODS: We searched Medline and PubMed for relevant publications comparing LT and LR in HCC patients during the time period from 1990 to 2022, prior to March 31, 2023. A total of 63 studies involving 19,804 patients - of whom 8178 patients received a liver graft and 11,626 underwent partial hepatectomy - were included in this meta-analysis. RESULTS: LT is associated with significantly better 5-year overall survival (OS) (64.83%) and recurrence-free survival (RFS) (70.20%) than LR (OS: 50.83%, OR: 1.79, p < 0.001; RFS: 34.46%, OR: 5.32, p < 0.001). However, these differences are not as evident in short-term intervals. Older cohorts showed comparable disparities between the outcome of the respective modalities, as did newer cohorts after 2005. This might be due to the similar improvement in survival rates that were observed for both, LT (15-23%) and LR (12-20%) during the last 30 years. CONCLUSION: LT still outperforms LR in the therapy of HCC in terms of long-term survival rates. Yet, LR outcome has remarkably improved which is of major importance in reference to the well-known limitations that occur in LT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver TransplantationLiver NeoplasmsHumansHepatectomySurvival RateRetrospective StudiesNeoplasm Recurrence, LocalTreatment Outcome

Stichwörter der Autor:innen

HCCHepatocellular carcinomaLiver resectionLiver transplantationLiving-donor liver transplantationmeta-Analysis

Autor:innen und Institutionen

  • Department of General, Visceral and Transplantation Surgery, LMU University Hospital, LMU Munich, Germany. Electronic address: moritz.drefs@med.uni-muenchen.de.
  • Department of General, Visceral and Transplantation Surgery, LMU University Hospital, LMU Munich, Germany; Faculty of Medicine, LMU Munich, Germany; Medical Centers Gollierplatz and Nymphenburg, Munich, Germany.
  • Department of General, Visceral and Transplantation Surgery, LMU University Hospital, LMU Munich, Germany.
  • Department of General, Visceral and Transplantation Surgery, LMU University Hospital, LMU Munich, Germany; Bavarian Cancer Research Center (BZKF), Munich, Germany.
  • Department of General, Visceral and Transplantation Surgery, LMU University Hospital, LMU Munich, Germany; Faculty of Medicine, LMU Munich, Germany; Bavarian Cancer Research Center (BZKF), Munich, Germany.
  • Department of General, Visceral and Transplantation Surgery, LMU University Hospital, LMU Munich, Germany; Transplantation Center Munich, LMU University Hospital, LMU Munich, Germany.

Zitieren

APA

Drefs, M., Schoenberg, M. B., Börner, N., Koliogiannis, D., Koch, D. T., Schirren, M. J., Andrassy, J., Bazhin, A. V., Werner, J., & Guba, M. O. (2024). Changes of long-term survival of resection and liver transplantation in hepatocellular carcinoma throughout the years: A meta-analysis. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2024.107952

Vancouver

Drefs M, Schoenberg MB, Börner N, Koliogiannis D, Koch DT, Schirren MJ, et al. Changes of long-term survival of resection and liver transplantation in hepatocellular carcinoma throughout the years: A meta-analysis. European Journal of Surgical Oncology. 2024. doi:10.1016/j.ejso.2024.107952

BibTeX
@article{Drefs2024,
  author = {Drefs, Moritz and Schoenberg, Markus B and Börner, Nikolaus and Koliogiannis, Dionysios and Koch, Dominik T and Schirren, Malte J and Andrassy, Joachim and Bazhin, Alexandr V and Werner, Jens and Guba, Markus O},
  title = {Changes of long-term survival of resection and liver transplantation in hepatocellular carcinoma throughout the years: A meta-analysis},
  journal = {European Journal of Surgical Oncology},
  year = {2024},
  doi = {10.1016/j.ejso.2024.107952}
}
Kostenlos starten →